BIOTECH

Funds management

The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline 52 per cent year-to-date and hit its funds under manageme...

Funds management

The listed biotech sector has had a significant sell-off over the past year but innovations still abound, leading investors to ask whether it is time to get back into the...

Funds management

Investors are accused of being ‘theme junkies’ as they chase the latest mega-trend but which theme has seen the strongest returns over the past year?...

Funds management

The COVID-19 vaccine roll-out may be slow in Australia but exposure to one of its creators has boosted the Platinum European fund after the company’s value doubled to US$...

Funds management

Australian investors tend to have a concentrated domestic exposure to biotechnology but may be missing the growth and diversification offered overseas, according to ETF S...

Funds management

Global healthcare stocks are expected to perform strongly over the long term thanks to a huge boost in healthcare spending across developing and developed economies trigg...

Funds management

As markets react to the news of a successful COVID-19 vaccine trial from US pharma Pfizer and German biotech firm BioNTech, there are just three funds holding these stock...

Funds management

Biotechnology is just as exciting as Amazon or Afterpay but often fails to receive the same attention, according to Platinum. ...

Funds management

Pengana has increased its weighting to healthcare in its High Conviction Equities fund as it is confident in the recovery of spending in the sector....

Funds management

Despite the world rushing to find a vaccine for COVID-19, biotech and healthcare funds have not been able to maintain their former strong returns. ...

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

So we are now underwriting criminal scams?...

5 months ago

Glad to see the back of you Steve. You made financial more expensive, not more affordable as you claim, and presided ...

5 months 1 week ago

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

7 months 1 week ago

The FSCP has issued a written direction to an adviser who charged clients “extraordinary fees” for inappropriate and conflicted advice, as well as encouraged them to swit...

1 week 6 days ago

ASIC has cancelled the AFSL of an advice firm associated with Shield and First Guardian collapses, and permanently banned its responsible manager. ...

3 weeks 2 days ago

ASIC has confirmed the industry funding levy for the 2024–25 financial year, and how much licensees can expect to pay....

3 days 15 hours ago